Ariad appoints activist investor Denner to board
This article was originally published in Scrip
Oncology company Ariad has appointed Dr Alexander Denner to its board of directors for a two year term. Dr Denner, who currently serves as chief investment officer and founding partner of Sarissa Capital Management, is an activist investor who previously worked with the notorious Carl Icahn at Icahn Capital. Dr Denner is currently also a director of Biogen Idec and Vivus. Ariad will also appoint another independent director to the board, who will be subject to Dr Denner's approval.